×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Teva to Present at the 2024 Bank of America Healthcare Conference
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at...
6 hours ago
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO
Reuters
Teva Pharmaceutical Industries will remain a single company for generic and branded drugs, and expects to see significant interest in its...
2 months ago
GSK: 3 Top Pharma Stocks for May 2024
StockNews
GSK plc(NYSE:GSK): The pharmaceutical sector is experiencing rapid growth, driven by the ever-rising healthcare needs and the adoption of...
2 days ago
Who wants to buy Teva's API business?
Chemical & Engineering News
Teva Pharmaceutical Industries earlier sold this pharmaceutical chemical pilot plant in Malvern, Pennsylvania, to Flamma Group.
1 month ago
Boosted by $19M equity package, Teva's Richard Francis joins upper echelons of pharma CEO pay ranks
Fierce Pharma
Riding high on Teva's success under its recent “Pivot to Growth” strategy, chief executive Richard Francis—in his first year at the helm of...
2 weeks ago
Teva Pharma sees lower 2024 profit but higher sales after large Q4 beat
Yahoo Finance
JERUSALEM (Reuters) -Teva Pharmaceuticals forecast lower profit but higher sales this year after a strong 2023 fourth quarter boosted by a...
3 months ago
Teva CEO says production and distribution in Israel remain largely unaffected by war
The Times of Israel
Israel's Teva Pharmaceuticals Industries Ltd. said Tuesday that manufacturing has not been affected despite the country being more than four...
2 months ago
Teva Pharma (TEVA) and Teva (TEVA) Announce FDA Approval of SELARSDI
StreetInsider
Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), today announced that...
2 weeks ago
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
The Motley Fool
As per the terms of the collaboration agreement, Teva received an upfront payment of 500 million in the fourth quarter of 2023, which was...
3 months ago
Teva's 2023 Healthy Future Report Showcases Renewed Sustainability Strategy and Ambitious Targets
Business Wire
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today published its 2023 Healthy Future Report, sharing its actions to promote...
16 hours ago